Enzalutamide
Pfizer,Astellas
['prostate']
dr. david olmos presents an extensive effort to understand the hrr mutations in first line metastatic castration resistant #prostatecancer #asco23 
Clinical researcher focused on #ProstateCancer, early recurrence (#BCR)  & #immunotherapy. Views are my own & do not represent the National Cancer Institute